^
    over1year
    K19017-004: Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer (clinicaltrials.gov)
    P1, N=30, Not yet recruiting, Tongji Hospital
    New P1 trial • Oncolytic virus
    |
    MUC16 (Mucin 16, Cell Surface Associated)
    |
    Avastin (bevacizumab) • cisplatin • carboplatin • albumin-bound paclitaxel • KM1